Search

Your search keyword '"Flood, Louise"' showing total 15 results
Start Over Author "Flood, Louise" Database Supplemental Index
15 results on '"Flood, Louise"'

1. 4CMenB sustained vaccine effectiveness against invasive meningococcal B disease and gonorrhoea at three years post programme implementation.

Author

Wang, Bing, Giles, Lynne, Andraweera, Prabha, McMillan, Mark, Almond, Sara, Beazley, Rebecca, Mitchell, Janine, Ahoure, Michele, Denehy, Emma, Flood, Louise, and Marshall, Helen

Abstract

To evaluate persistence of vaccine effectiveness (VE) and vaccine impact (VI) on invasive meningococcal B (MenB) disease and gonorrhoea at three years after implementation of a state funded 4CMenB programme for infants, children, adolescents and young people in South Australia. VI was assessed using a Poisson or negative binomial regression model, and VE was estimated using screening and case-control methods. Chlamydia controls were used to estimate VE in the primary analysis to control potential confounding effects such as high-risk sexual behaviour associated with sexually transmitted infections. During the three-year programme, reductions of 63.1% (95%CI 29.0–80.9%) and 78.5% (95%CI 33.0–93.1%) in incidence of MenB disease were observed in infants and adolescents, respectively. There were no cases in infants who had received three doses of 4CMenB. Two-dose VE against MenB disease was 90.7% (95%CI 6.9–99.1%) for the childhood programme and 83.5% (95%CI 0–98.2%) for the adolescent programme. Two-dose VE against gonorrhoea in adolescents was 33.2% (95%CI 15.9–47.0%). Lower VE estimates were demonstrated after 36 months post-vaccination (23.2% (95%CI 0–47.5%)> 36 months post-vaccination compared to 34.9% (95%CI 15.0–50.1%) within 6–36 months). Higher VE estimates were found after excluding patients with repeat gonorrhoea infections (37.3%, 95%CI 19.8–51.0%). For gonorrhoea cases co-infected with chlamydia VE was maintained (44.7% (95%CI 17.1–63.1%). The third-year evaluation results show persistent vaccine effectiveness of 4CMenB against MenB disease in infants and adolescents. As this is the first ongoing programme for adolescents, moderate vaccine protection against gonorrhoea with waning effectiveness three years post-vaccination was demonstrated in adolescents and young adults. The additional protection of 4CMenB vaccine against gonorrhoea, likely through cross-protection should be considered in cost-effectiveness analyses. A booster dose may need to be further evaluated and considered in adolescents due to waning protection against gonorrhoea demonstrated after 36 months post-vaccination. • Investigating the waning protection against gonorrhoea> 36 months after vaccination. • Confirming high vaccine protection against Meningococcal B disease. • Confirming sustained moderate cross-protection against gonorrhoea. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

2. Short Message Service Reminder Nudge for Parents and Influenza Vaccination Uptake in Children and Adolescents With Special Risk Medical Conditions: The Flutext-4U Randomized Clinical Trial

Author

Tuckerman, Jane, Harper, Kelly, Sullivan, Thomas R., Cuthbert, Alana R., Fereday, Jennifer, Couper, Jennifer, Smith, Nicholas, Tai, Andrew, Kelly, Andrew, Couper, Richard, Friswell, Mark, Flood, Louise, Blyth, Christopher C., Danchin, Margie, and Marshall, Helen S.

Abstract

IMPORTANCE: Children with chronic medical conditions are at increased risk of severe influenza. Uptake of influenza vaccination in children and adolescents with these identified special risk medical conditions (SRMCs) is suboptimal. OBJECTIVE: To assess the effectiveness of Flutext-4U, a parent short message service (SMS) reminder nudge intervention, in increasing influenza immunization in children and adolescents with SRMCs. DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial was conducted at a tertiary pediatric hospital in Adelaide, South Australia, from April 15 to September 30, 2021. Children and adolescents aged 6 months to younger than 18 years with SRMCs and a subspecialist outpatient appointment over a 5-month period during the Australian seasonal influenza vaccination season (April-August 2021) were eligible to participate. Follow-up was until September 30, 2021. INTERVENTIONS: Participants were randomly assigned (1:1 ratio) to control: clinician nudges (hospital vaccine availability, ease of access, and recommendation from hospital subspecialists) or SMS intervention (control conditions plus an additional SMS reminder nudge to parents), with randomization stratified by age group (<5 years, 5-14 years, or >14 to <18 years). MAIN OUTCOMES AND MEASURES: The primary outcome was influenza vaccination, as confirmed by the Australian Immunisation Register. RESULTS: A total of 600 participants (intervention group: 298 [49.7%]; mean [SD] age, 11.5 [4.6] years; 162 female participants [54.4%]; control group: 302 [50.3%]; mean [SD] age, 11.4 [4.7] years; 155 female participants [51.3%]) were included. Influenza vaccination was 38.6% (113 of 293) in the SMS intervention group compared with 26.2% (79 of 302) in the control group (adjusted odds ratio [aOR], 1.79; 95% CI, 1.27-2.55; P = .001). Time to vaccine receipt was significantly lower among SMS participants (adjusted hazard ratio, 1.67; 95% CI, 1.25-2.22; P < .001). For participants randomly assigned by June 15, a significantly greater proportion receiving the SMS intervention were vaccinated during the optimal delivery period April to June 30 (SMS group: 40.0% [76 of 190] vs 25.4% [50 of 197]; aOR, 1.97; 95% CI, 1.28-3.06; P = .002). CONCLUSIONS AND RELEVANCE: Results of this randomized clinical trial suggest that an additional SMS reminder nudge for parents delivered in the tertiary care hospital setting to children and adolescents with SMRCs resulted in higher influenza vaccine uptake compared with clinician nudges alone. TRIAL REGISTRATION: ANZCTR Identifier: ACTRN12621000463875

Published
2023
Full Text
View/download PDF

3. Lessons from a community vaccination programme to control a meningococcal disease serogroup W outbreak in remote South Australia, 2017.

Author

Flood, Louise, McConnell, Matthew, Molchanoff, Luda, Dodd, Zell, Sisnowski, Jana, Fidock, Melissa, Miller, Tina, Borresen, Karli, Vogt, Hannah, and Lane, Andrew

Subjects
MENINGOCOCCAL infections, INDIGENOUS Australians, INDIGENOUS children, MENINGOCOCCAL vaccines, VACCINATION, PREVENTIVE medicine
Abstract

Problem: From December 2016 to February 2017, two cases of invasive meningococcal disease and one case of meningococcal conjunctivitis, all serogroup W, occurred in Aboriginal children in the Ceduna region of South Australia. The clustering of cases in time and place met the threshold for a community outbreak. Context: The Ceduna region is a remote part of South Australia, with more than 25% of the population identifying as Aboriginal or Torres Strait Islander. Action: As part of the outbreak response, a community-wide meningococcal vaccination programme against serogroups A, C, W and Y was implemented in a collaboration among different agencies of the South Australia Department for Health and Wellbeing, Aboriginal health and community services providers, and other local service providers and government agencies. The programme comprised an outbreak vaccination schedule, targeting all people aged > 2 months residing in the cases' places of residence or in towns with close links. Outcome: Between March and June 2017, 3383 persons were vaccinated, achieving an estimated coverage of 71-85% of the target population, with 31% (n = 1034) of those vaccinated identifying as Aboriginal or Torres Strait Islander. No local cases of serogroup W occurred during the vaccination programme, but two further cases were notified by the end of 2018. Discussion: The participation of a large number of local and non-health-sector stakeholders in programme planning and implementation, a clear response management structure and high community acceptability were identified as key factors that contributed to the programme achieving high vaccination coverage. The need to develop standard operating procedures for community-based outbreak response interventions to ease logistical challenges was considered an important lesson learnt. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

4. First statewide meningococcal B vaccine program in infants, children and adolescents: evidence for implementation in South Australia.

Author

Marshall, Helen S, Lally, Noel, Flood, Louise, and Phillips, Paddy

Abstract

Invasive meningococcal disease (IMD) is an uncommon but life-threatening infection caused by Neisseria meningitidis. Serogroups B, C, W and Y cause most IMD cases in Australia. The highest incidence occurs in children under 5 years of age. A second peak occurs in adolescents and young adults, which is also the age of highest carriage prevalence of N. meningitidis. Meningococcal serogroup B (MenB) disease predominated nationally before 2016 and has remained the predominant cause of IMD in South Australia with 82% of cases, compared with 35% in New South Wales, 35% in Queensland, 9% in Victoria, 29% in Western Australia and 36% nationally in 2016. MenB vaccination is recommended by the Australian Technical Advisory Group on Immunisation for infants up to 2 years of age and adolescents aged 15-19 years (age 15-24 years for at-risk groups, such as people living in close quarters or smokers), laboratory workers with exposure to N. meningitidis, and Aboriginal and Torres Strait Islander children from age 2 months to 19 years. Due to the epidemiology and disease burden from MenB, a meningococcal B vaccine program has been implemented in South Australia for individuals with age-specific incidence rates higher than the mean rate of 2.8/100 000 population in South Australia in the period 2000-2017, including infants, young children (< 4 years) and adolescents (15-20 years). Program evaluation of vaccine effectiveness against IMD is important. As observational evidence also suggests 4CMenB may have an impact on Neisseria gonorrhoeae with genetic homology between bacterial species, the vaccine impact on gonorrhoea will also be assessed. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

5. Evaluating the effectiveness of the 4CMenB vaccine against invasive meningococcal disease and gonorrhoea in an infant, child and adolescent program: protocol

Author

Marshall, Helen S., Andraweera, Prabha H., Wang, Bing, McMillan, Mark, Koehler, Ann P., Lally, Noel, Almond, Sara, Denehy, Emma, A’Houre, Michele, Giles, Lynne C., and Flood, Louise

Abstract

ABSTRACTInvasive meningococcal disease causes significant morbidity and mortality worldwide, with serogroup B being one of the predominant serogroups in Australia for many years. The South Australian (SA) State Government recently funded the introduction of a 4CMenB vaccination program for infants, children and adolescents. In addition to protecting against invasive meningococcal disease, emerging evidence suggests the 4CMenB vaccine may also be effective against gonorrhoea due to genetic similarities between Neisseria meningitidis and Neisseria gonorrhoeae. The proposed project aims to evaluate the effectiveness of the SA 4CMenB vaccination program against invasive meningococcal disease and gonorrhoea through a combination of observational studies using routine surveillance and research data. The main methodological approaches involve an interrupted time series regression model, screening, and case-control analyses with different sets of controls to estimate vaccine impact and effectiveness. These analyses are designed to minimize potential biases inherent in all observational studies and to provide critical data on the effectiveness of the 4CMenB vaccine against two diseases of major global public health concern.

Published
2021
Full Text
View/download PDF

6. First statewide meningococcal B vaccine program in infants, children and adolescents: evidence for implementation in South Australia

Author

Marshall, Helen S, Lally, Noel, Flood, Louise, and Phillips, Paddy

Abstract

Invasive meningococcal disease (IMD) is an uncommon but life‐threatening infection caused by Neisseria meningitidis. Serogroups B, C, W and Y cause most IMDcases in Australia. The highest incidence occurs in children under 5 years of age. A second peak occurs in adolescents and young adults, which is also the age of highest carriage prevalence of N. meningitidis.Meningococcal serogroup B (MenB) disease predominated nationally before 2016 and has remained the predominant cause of IMDin South Australia with 82% of cases, compared with 35% in New South Wales, 35% in Queensland, 9% in Victoria, 29% in Western Australia and 36% nationally in 2016.MenB vaccination is recommended by the Australian Technical Advisory Group on Immunisation for infants up to 2 years of age and adolescents aged 15–19 years (age 15–24 years for at‐risk groups, such as people living in close quarters or smokers), laboratory workers with exposure to N. meningitidis, and Aboriginal and Torres Strait Islander children from age 2 months to 19 years.Due to the epidemiology and disease burden from MenB, a meningococcal B vaccine program has been implemented in South Australia for individuals with age‐specific incidence rates higher than the mean rate of 2.8/100 000 population in South Australia in the period 2000–2017, including infants, young children (< 4 years) and adolescents (15–20 years).Program evaluation of vaccine effectiveness against IMDis important. As observational evidence also suggests 4CMenB may have an impact on Neisseria gonorrhoeaewith genetic homology between bacterial species, the vaccine impact on gonorrhoea will also be assessed.

Published
2020
Full Text
View/download PDF

7. An increase in neural tube defect notifications, South Australia, 2009-2010.

Author

Flood, Louise, Scheil, Wendy, Nguyen, Anh-Minh, Sage, Leonie, and Scott, Joan

Subjects
NEURAL tube defects, CHILDBIRTH, STILLBIRTH, BIRTH weight, ABORTION, QUANTITATIVE research, CHI-squared test
Abstract

Introduction: In South Australia, reporting of live births, stillbirths of at least 20 weeks or 400g birth weight, termination of pregnancies and congenital anomalies is mandated. We describe the investigation of an increase in notifications of neural tube defects (NTDs) in South Australia in 2009 and 2010 using data from several surveillance systems. Methods: NTD trend data from 1966 to 2010 were reviewed. Comparisons of pregnancies affected by an NTD in 2009 and 2010 were made with pregnancies affected by an NTD in the period 2003-2008 and with all pregnancies in 2009 and 2010. Statistical analysis was undertaken using Poisson regression, chi-squared or Fisher's exact tests. Results: The prevalence of NTD-affected pregnancies was 1.95 per 1000 births (39 cases) in 2010 and 1.91 per 1000 births in 2009 (38 cases), the highest annual rates since 1991. Case series comparisons indicated women with NTD-affected pregnancies in 2009 and 2010 were less likely to be Caucasian compared with women who had NTD-affected pregnancies in the period 2003-2008. Women born in the Middle East and African region (n = 7) were significantly more likely to have NTD-affected pregnancies in the years 2009 and 2010 (relative risk: 3.03; 95% confidence interval: 1.39-6.62) compared with women born in the Oceania region. Discussion: The increased notifications of NTDs can only be partially explained by the increase in numbers of women from the Middle East and African region, with no other contributory causes revealed. This analysis highlighted areas where prevention efforts should be strengthened and surveillance data improved. [ABSTRACT FROM AUTHOR]

Published
2013
Full Text
View/download PDF

8. Epidemiology of basketball and netball injuries that resulted in hospital admission in Australia, 2000-2004.

Author

Flood, Louise and Harrison, James E.

Abstract

The article discusses a study which examined the injuries sustained in basketball and netball which led to hospitalization in Australia. The study used the data from the National Hospital Morbidity Database from July 2000 to June 2004. It discovered 5,090 hospital admissions related to basketball, and 4,596 admissions related to netball. Fractures, anterior cruciate ligament rupture and Achilles tendon injury were found to be the most common sustained injury.

Published
2009
Full Text
View/download PDF

9. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Author

Murray, Christopher J L, Vos, Theo, Lozano, Rafael, Naghavi, Mohsen, Flaxman, Abraham D, Michaud, Catherine, Ezzati, Majid, Shibuya, Kenji, Salomon, Joshua A, Abdalla, Safa, Aboyans, Victor, Abraham, Jerry, Ackerman, Ilana, Aggarwal, Rakesh, Ahn, Stephanie Y, Ali, Mohammed K, AlMazroa, Mohammad A, Alvarado, Miriam, Anderson, H Ross, Anderson, Laurie M, Andrews, Kathryn G, Atkinson, Charles, Baddour, Larry M, Bahalim, Adil N, Barker-Collo, Suzanne, Barrero, Lope H, Bartels, David H, Basáñez, Maria-Gloria, Baxter, Amanda, Bell, Michelle L, Benjamin, Emelia J, Bennett, Derrick, Bernabé, Eduardo, Bhalla, Kavi, Bhandari, Bishal, Bikbov, Boris, Abdulhak, Aref Bin, Birbeck, Gretchen, Black, James A, Blencowe, Hannah, Blore, Jed D, Blyth, Fiona, Bolliger, Ian, Bonaventure, Audrey, Boufous, Soufiane, Bourne, Rupert, Boussinesq, Michel, Braithwaite, Tasanee, Brayne, Carol, Bridgett, Lisa, Brooker, Simon, Brooks, Peter, Brugha, Traolach S, Bryan-Hancock, Claire, Bucello, Chiara, Buchbinder, Rachelle, Buckle, Geoffrey, Budke, Christine M, Burch, Michael, Burney, Peter, Burstein, Roy, Calabria, Bianca, Campbell, Benjamin, Canter, Charles E, Carabin, Hélène, Carapetis, Jonathan, Carmona, Loreto, Cella, Claudia, Charlson, Fiona, Chen, Honglei, Cheng, Andrew Tai-Ann, Chou, David, Chugh, Sumeet S, Coffeng, Luc E, Colan, Steven D, Colquhoun, Samantha, Colson, K Ellicott, Condon, John, Connor, Myles D, Cooper, Leslie T, Corriere, Matthew, Cortinovis, Monica, de Vaccaro, Karen Courville, Couser, William, Cowie, Benjamin C, Criqui, Michael H, Cross, Marita, Dabhadkar, Kaustubh C, Dahiya, Manu, Dahodwala, Nabila, Damsere-Derry, James, Danaei, Goodarz, Davis, Adrian, Leo, Diego De, Degenhardt, Louisa, Dellavalle, Robert, Delossantos, Allyne, Denenberg, Julie, Derrett, Sarah, Des Jarlais, Don C, Dharmaratne, Samath D, Dherani, Mukesh, Diaz-Torne, Cesar, Dolk, Helen, Dorsey, E Ray, Driscoll, Tim, Duber, Herbert, Ebel, Beth, Edmond, Karen, Elbaz, Alexis, Ali, Suad Eltahir, Erskine, Holly, Erwin, Patricia J, Espindola, Patricia, Ewoigbokhan, Stalin E, Farzadfar, Farshad, Feigin, Valery, Felson, David T, Ferrari, Alize, Ferri, Cleusa P, Fèvre, Eric M, Finucane, Mariel M, Flaxman, Seth, Flood, Louise, Foreman, Kyle, Forouzanfar, Mohammad H, Fowkes, Francis Gerry R, Fransen, Marlene, Freeman, Michael K, Gabbe, Belinda J, Gabriel, Sherine E, Gakidou, Emmanuela, Ganatra, Hammad A, Garcia, Bianca, Gaspari, Flavio, Gillum, Richard F, Gmel, Gerhard, Gonzalez-Medina, Diego, Gosselin, Richard, Grainger, Rebecca, Grant, Bridget, Groeger, Justina, Guillemin, Francis, Gunnell, David, Gupta, Ramyani, Haagsma, Juanita, Hagan, Holly, Halasa, Yara A, Hall, Wayne, Haring, Diana, Haro, Josep Maria, Harrison, James E, Havmoeller, Rasmus, Hay, Roderick J, Higashi, Hideki, Hill, Catherine, Hoen, Bruno, Hoffman, Howard, Hotez, Peter J, Hoy, Damian, Huang, John J, Ibeanusi, Sydney E, Jacobsen, Kathryn H, James, Spencer L, Jarvis, Deborah, Jasrasaria, Rashmi, Jayaraman, Sudha, Johns, Nicole, Jonas, Jost B, Karthikeyan, Ganesan, Kassebaum, Nicholas, Kawakami, Norito, Keren, Andre, Khoo, Jon-Paul, King, Charles H, Knowlton, Lisa Marie, Kobusingye, Olive, Koranteng, Adofo, Krishnamurthi, Rita, Laden, Francine, Lalloo, Ratilal, Laslett, Laura L, Lathlean, Tim, Leasher, Janet L, Lee, Yong Yi, Leigh, James, Levinson, Daphna, Lim, Stephen S, Limb, Elizabeth, Lin, John Kent, Lipnick, Michael, Lipshultz, Steven E, Liu, Wei, Loane, Maria, Ohno, Summer Lockett, Lyons, Ronan, Mabweijano, Jacqueline, MacIntyre, Michael F, Malekzadeh, Reza, Mallinger, Leslie, Manivannan, Sivabalan, Marcenes, Wagner, March, Lyn, Margolis, David J, Marks, Guy B, Marks, Robin, Matsumori, Akira, Matzopoulos, Richard, Mayosi, Bongani M, McAnulty, John H, McDermott, Mary M, McGill, Neil, McGrath, John, Medina-Mora, Maria Elena, Meltzer, Michele, Memish, Ziad A, Mensah, George A, Merriman, Tony R, Meyer, Ana-Claire, Miglioli, Valeria, Miller, Matthew, Miller, Ted R, Mitchell, Philip B, Mock, Charles, Mocumbi, Ana Olga, Moffitt, Terrie E, Mokdad, Ali A, Monasta, Lorenzo, Montico, Marcella, Moradi-Lakeh, Maziar, Moran, Andrew, Morawska, Lidia, Mori, Rintaro, Murdoch, Michele E, Mwaniki, Michael K, Naidoo, Kovin, Nair, M Nathan, Naldi, Luigi, Narayan, K M Venkat, Nelson, Paul K, Nelson, Robert G, Nevitt, Michael C, Newton, Charles R, Nolte, Sandra, Norman, Paul, Norman, Rosana, O'Donnell, Martin, O'Hanlon, Simon, Olives, Casey, Omer, Saad B, Ortblad, Katrina, Osborne, Richard, Ozgediz, Doruk, Page, Andrew, Pahari, Bishnu, Pandian, Jeyaraj Durai, Rivero, Andrea Panozo, Patten, Scott B, Pearce, Neil, Padilla, Rogelio Perez, Perez-Ruiz, Fernando, Perico, Norberto, Pesudovs, Konrad, Phillips, David, Phillips, Michael R, Pierce, Kelsey, Pion, Sébastien, Polanczyk, Guilherme V, Polinder, Suzanne, Pope, C Arden, Popova, Svetlana, Porrini, Esteban, Pourmalek, Farshad, Prince, Martin, Pullan, Rachel L, Ramaiah, Kapa D, Ranganathan, Dharani, Razavi, Homie, Regan, Mathilda, Rehm, Jürgen T, Rein, David B, Remuzzi, Guiseppe, Richardson, Kathryn, Rivara, Frederick P, Roberts, Thomas, Robinson, Carolyn, De Leòn, Felipe Rodriguez, Ronfani, Luca, Room, Robin, Rosenfeld, Lisa C, Rushton, Lesley, Sacco, Ralph L, Saha, Sukanta, Sampson, Uchechukwu, Sanchez-Riera, Lidia, Sanman, Ella, Schwebel, David C, Scott, James Graham, Segui-Gomez, Maria, Shahraz, Saeid, Shepard, Donald S, Shin, Hwashin, Shivakoti, Rupak, Silberberg, Donald, Singh, David, Singh, Gitanjali M, Singh, Jasvinder A, Singleton, Jessica, Sleet, David A, Sliwa, Karen, Smith, Emma, Smith, Jennifer L, Stapelberg, Nicolas JC, Steer, Andrew, Steiner, Timothy, Stolk, Wilma A, Stovner, Lars Jacob, Sudfeld, Christopher, Syed, Sana, Tamburlini, Giorgio, Tavakkoli, Mohammad, Taylor, Hugh R, Taylor, Jennifer A, Taylor, William J, Thomas, Bernadette, Thomson, W Murray, Thurston, George D, Tleyjeh, Imad M, Tonelli, Marcello, Towbin, Jeffrey A, Truelsen, Thomas, Tsilimbaris, Miltiadis K, Ubeda, Clotilde, Undurraga, Eduardo A, van der Werf, Marieke J, van Os, Jim, Vavilala, Monica S, Venketasubramanian, N, Wang, Mengru, Wang, Wenzhi, Watt, Kerrianne, Weatherall, David J, Weinstock, Martin A, Weintraub, Robert, Weisskopf, Marc G, Weissman, Myrna M, White, Richard A, Whiteford, Harvey, Wiebe, Natasha, Wiersma, Steven T, Wilkinson, James D, Williams, Hywel C, Williams, Sean RM, Witt, Emma, Wolfe, Frederick, Woolf, Anthony D, Wulf, Sarah, Yeh, Pon-Hsiu, Zaidi, Anita KM, Zheng, Zhi-Jie, Zonies, David, and Lopez, Alan D

Abstract

Measuring disease and injury burden in populations requires a composite metric that captures both premature mortality and the prevalence and severity of ill-health. The 1990 Global Burden of Disease study proposed disability-adjusted life years (DALYs) to measure disease burden. No comprehensive update of disease burden worldwide incorporating a systematic reassessment of disease and injury-specific epidemiology has been done since the 1990 study. We aimed to calculate disease burden worldwide and for 21 regions for 1990, 2005, and 2010 with methods to enable meaningful comparisons over time.

Published
2012
Full Text
View/download PDF

10. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Author

Vos, Theo, Flaxman, Abraham D, Naghavi, Mohsen, Lozano, Rafael, Michaud, Catherine, Ezzati, Majid, Shibuya, Kenji, Salomon, Joshua A, Abdalla, Safa, Aboyans, Victor, Abraham, Jerry, Ackerman, Ilana, Aggarwal, Rakesh, Ahn, Stephanie Y, Ali, Mohammed K, AlMazroa, Mohammad A, Alvarado, Miriam, Anderson, H Ross, Anderson, Laurie M, Andrews, Kathryn G, Atkinson, Charles, Baddour, Larry M, Bahalim, Adil N, Barker-Collo, Suzanne, Barrero, Lope H, Bartels, David H, Basáñez, Maria-Gloria, Baxter, Amanda, Bell, Michelle L, Benjamin, Emelia J, Bennett, Derrick, Bernabé, Eduardo, Bhalla, Kavi, Bhandari, Bishal, Bikbov, Boris, Abdulhak, Aref Bin, Birbeck, Gretchen, Black, James A, Blencowe, Hannah, Blore, Jed D, Blyth, Fiona, Bolliger, Ian, Bonaventure, Audrey, Boufous, Soufiane, Bourne, Rupert, Boussinesq, Michel, Braithwaite, Tasanee, Brayne, Carol, Bridgett, Lisa, Brooker, Simon, Brooks, Peter, Brugha, Traolach S, Bryan-Hancock, Claire, Bucello, Chiara, Buchbinder, Rachelle, Buckle, Geoffrey, Budke, Christine M, Burch, Michael, Burney, Peter, Burstein, Roy, Calabria, Bianca, Campbell, Benjamin, Canter, Charles E, Carabin, Hélène, Carapetis, Jonathan, Carmona, Loreto, Cella, Claudia, Charlson, Fiona, Chen, Honglei, Cheng, Andrew Tai-Ann, Chou, David, Chugh, Sumeet S, Coffeng, Luc E, Colan, Steven D, Colquhoun, Samantha, Colson, K Ellicott, Condon, John, Connor, Myles D, Cooper, Leslie T, Corriere, Matthew, Cortinovis, Monica, de Vaccaro, Karen Courville, Couser, William, Cowie, Benjamin C, Criqui, Michael H, Cross, Marita, Dabhadkar, Kaustubh C, Dahiya, Manu, Dahodwala, Nabila, Damsere-Derry, James, Danaei, Goodarz, Davis, Adrian, De Leo, Diego, Degenhardt, Louisa, Dellavalle, Robert, Delossantos, Allyne, Denenberg, Julie, Derrett, Sarah, Des Jarlais, Don C, Dharmaratne, Samath D, Dherani, Mukesh, Diaz-Torne, Cesar, Dolk, Helen, Dorsey, E Ray, Driscoll, Tim, Duber, Herbert, Ebel, Beth, Edmond, Karen, Elbaz, Alexis, Ali, Suad Eltahir, Erskine, Holly, Erwin, Patricia J, Espindola, Patricia, Ewoigbokhan, Stalin E, Farzadfar, Farshad, Feigin, Valery, Felson, David T, Ferrari, Alize, Ferri, Cleusa P, Fèvre, Eric M, Finucane, Mariel M, Flaxman, Seth, Flood, Louise, Foreman, Kyle, Forouzanfar, Mohammad H, Fowkes, Francis Gerry R, Franklin, Richard, Fransen, Marlene, Freeman, Michael K, Gabbe, Belinda J, Gabriel, Sherine E, Gakidou, Emmanuela, Ganatra, Hammad A, Garcia, Bianca, Gaspari, Flavio, Gillum, Richard F, Gmel, Gerhard, Gosselin, Richard, Grainger, Rebecca, Groeger, Justina, Guillemin, Francis, Gunnell, David, Gupta, Ramyani, Haagsma, Juanita, Hagan, Holly, Halasa, Yara A, Hall, Wayne, Haring, Diana, Haro, Josep Maria, Harrison, James E, Havmoeller, Rasmus, Hay, Roderick J, Higashi, Hideki, Hill, Catherine, Hoen, Bruno, Hoffman, Howard, Hotez, Peter J, Hoy, Damian, Huang, John J, Ibeanusi, Sydney E, Jacobsen, Kathryn H, James, Spencer L, Jarvis, Deborah, Jasrasaria, Rashmi, Jayaraman, Sudha, Johns, Nicole, Jonas, Jost B, Karthikeyan, Ganesan, Kassebaum, Nicholas, Kawakami, Norito, Keren, Andre, Khoo, Jon-Paul, King, Charles H, Knowlton, Lisa Marie, Kobusingye, Olive, Koranteng, Adofo, Krishnamurthi, Rita, Lalloo, Ratilal, Laslett, Laura L, Lathlean, Tim, Leasher, Janet L, Lee, Yong Yi, Leigh, James, Lim, Stephen S, Limb, Elizabeth, Lin, John Kent, Lipnick, Michael, Lipshultz, Steven E, Liu, Wei, Loane, Maria, Ohno, Summer Lockett, Lyons, Ronan, Ma, Jixiang, Mabweijano, Jacqueline, MacIntyre, Michael F, Malekzadeh, Reza, Mallinger, Leslie, Manivannan, Sivabalan, Marcenes, Wagner, March, Lyn, Margolis, David J, Marks, Guy B, Marks, Robin, Matsumori, Akira, Matzopoulos, Richard, Mayosi, Bongani M, McAnulty, John H, McDermott, Mary M, McGill, Neil, McGrath, John, Medina-Mora, Maria Elena, Meltzer, Michele, Memish, Ziad A, Mensah, George A, Merriman, Tony R, Meyer, Ana-Claire, Miglioli, Valeria, Miller, Matthew, Miller, Ted R, Mitchell, Philip B, Mocumbi, Ana Olga, Moffitt, Terrie E, Mokdad, Ali A, Monasta, Lorenzo, Montico, Marcella, Moradi-Lakeh, Maziar, Moran, Andrew, Morawska, Lidia, Mori, Rintaro, Murdoch, Michele E, Mwaniki, Michael K, Naidoo, Kovin, Nair, M Nathan, Naldi, Luigi, Narayan, KM Venkat, Nelson, Paul K, Nelson, Robert G, Nevitt, Michael C, Newton, Charles R, Nolte, Sandra, Norman, Paul, Norman, Rosana, O'Donnell, Martin, O'Hanlon, Simon, Olives, Casey, Omer, Saad B, Ortblad, Katrina, Osborne, Richard, Ozgediz, Doruk, Page, Andrew, Pahari, Bishnu, Pandian, Jeyaraj Durai, Rivero, Andrea Panozo, Patten, Scott B, Pearce, Neil, Padilla, Rogelio Perez, Perez-Ruiz, Fernando, Perico, Norberto, Pesudovs, Konrad, Phillips, David, Phillips, Michael R, Pierce, Kelsey, Pion, Sébastien, Polanczyk, Guilherme V, Polinder, Suzanne, Pope, C Arden, Popova, Svetlana, Porrini, Esteban, Pourmalek, Farshad, Prince, Martin, Pullan, Rachel L, Ramaiah, Kapa D, Ranganathan, Dharani, Razavi, Homie, Regan, Mathilda, Rehm, Jürgen T, Rein, David B, Remuzzi, Guiseppe, Richardson, Kathryn, Rivara, Frederick P, Roberts, Thomas, Robinson, Carolyn, De Leòn, Felipe Rodriguez, Ronfani, Luca, Room, Robin, Rosenfeld, Lisa C, Rushton, Lesley, Sacco, Ralph L, Saha, Sukanta, Sampson, Uchechukwu, Sanchez-Riera, Lidia, Sanman, Ella, Schwebel, David C, Scott, James Graham, Segui-Gomez, Maria, Shahraz, Saeid, Shepard, Donald S, Shin, Hwashin, Shivakoti, Rupak, Silberberg, Donald, Singh, David, Singh, Gitanjali M, Singh, Jasvinder A, Singleton, Jessica, Sleet, David A, Sliwa, Karen, Smith, Emma, Smith, Jennifer L, Stapelberg, Nicolas JC, Steer, Andrew, Steiner, Timothy, Stolk, Wilma A, Stovner, Lars Jacob, Sudfeld, Christopher, Syed, Sana, Tamburlini, Giorgio, Tavakkoli, Mohammad, Taylor, Hugh R, Taylor, Jennifer A, Taylor, William J, Thomas, Bernadette, Thomson, W Murray, Thurston, George D, Tleyjeh, Imad M, Tonelli, Marcello, Towbin, Jeffrey A, Truelsen, Thomas, Tsilimbaris, Miltiadis K, Ubeda, Clotilde, Undurraga, Eduardo A, van der Werf, Marieke J, van Os, Jim, Vavilala, Monica S, Venketasubramanian, N, Wang, Mengru, Wang, Wenzhi, Watt, Kerrianne, Weatherall, David J, Weinstock, Martin A, Weintraub, Robert, Weisskopf, Marc G, Weissman, Myrna M, White, Richard A, Whiteford, Harvey, Wiersma, Steven T, Wilkinson, James D, Williams, Hywel C, Williams, Sean RM, Witt, Emma, Wolfe, Frederick, Woolf, Anthony D, Wulf, Sarah, Yeh, Pon-Hsiu, Zaidi, Anita KM, Zheng, Zhi-Jie, Zonies, David, Lopez, Alan D, and Murray, Christopher JL

Abstract

Non-fatal health outcomes from diseases and injuries are a crucial consideration in the promotion and monitoring of individual and population health. The Global Burden of Disease (GBD) studies done in 1990 and 2000 have been the only studies to quantify non-fatal health outcomes across an exhaustive set of disorders at the global and regional level. Neither effort quantified uncertainty in prevalence or years lived with disability (YLDs).

Published
2012
Full Text
View/download PDF

11. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010

Author

Salomon, Joshua A, Vos, Theo, Hogan, Daniel R, Gagnon, Michael, Naghavi, Mohsen, Mokdad, Ali, Begum, Nazma, Shah, Razibuzzaman, Karyana, Muhammad, Kosen, Soewarta, Farje, Mario Reyna, Moncada, Gilberto, Dutta, Arup, Sazawal, Sunil, Dyer, Andrew, Seiler, Jason, Aboyans, Victor, Baker, Lesley, Baxter, Amanda, Benjamin, Emelia J, Bhalla, Kavi, Abdulhak, Aref Bin, Blyth, Fiona, Bourne, Rupert, Braithwaite, Tasanee, Brooks, Peter, Brugha, Traolach S, Bryan-Hancock, Claire, Buchbinder, Rachelle, Burney, Peter, Calabria, Bianca, Chen, Honglei, Chugh, Sumeet S, Cooley, Rebecca, Criqui, Michael H, Cross, Marita, Dabhadkar, Kaustubh C, Dahodwala, Nabila, Davis, Adrian, Degenhardt, Louisa, Díaz-Torné, Cesar, Dorsey, E Ray, Driscoll, Tim, Edmond, Karen, Elbaz, Alexis, Ezzati, Majid, Feigin, Valery, Ferri, Cleusa P, Flaxman, Abraham D, Flood, Louise, Fransen, Marlene, Fuse, Kana, Gabbe, Belinda J, Gillum, Richard F, Haagsma, Juanita, Harrison, James E, Havmoeller, Rasmus, Hay, Roderick J, Hel-Baqui, Abdullah, Hoek, Hans W, Hoffman, Howard, Hogeland, Emily, Hoy, Damian, Jarvis, Deborah, Jonas, Jost B, Karthikeyan, Ganesan, Knowlton, Lisa Marie, Lathlean, Tim, Leasher, Janet L, Lim, Stephen S, Lipshultz, Steven E, Lopez, Alan D, Lozano, Rafael, Lyons, Ronan, Malekzadeh, Reza, Marcenes, Wagner, March, Lyn, Margolis, David J, McGill, Neil, McGrath, John, Mensah, George A, Meyer, Ana-Claire, Michaud, Catherine, Moran, Andrew, Mori, Rintaro, Murdoch, Michele E, Naldi, Luigi, Newton, Charles R, Norman, Rosana, Omer, Saad B, Osborne, Richard, Pearce, Neil, Perez-Ruiz, Fernando, Perico, Norberto, Pesudovs, Konrad, Phillips, David, Pourmalek, Farshad, Prince, Martin, Rehm, Jürgen T, Remuzzi, Guiseppe, Richardson, Kathryn, Room, Robin, Saha, Sukanta, Sampson, Uchechukwu, Sanchez-Riera, Lidia, Segui-Gomez, Maria, Shahraz, Saeid, Shibuya, Kenji, Singh, David, Sliwa, Karen, Smith, Emma, Soerjomataram, Isabelle, Steiner, Timothy, Stolk, Wilma A, Stovner, Lars Jacob, Sudfeld, Christopher, Taylor, Hugh R, Tleyjeh, Imad M, van der Werf, Marieke J, Watson, Wendy L, Weatherall, David J, Weintraub, Robert, Weisskopf, Marc G, Whiteford, Harvey, Wilkinson, James D, Woolf, Anthony D, Zheng, Zhi-Jie, and Murray, Christopher JL

Abstract

Measurement of the global burden of disease with disability-adjusted life-years (DALYs) requires disability weights that quantify health losses for all non-fatal consequences of disease and injury. There has been extensive debate about a range of conceptual and methodological issues concerning the definition and measurement of these weights. Our primary objective was a comprehensive re-estimation of disability weights for the Global Burden of Disease Study 2010 through a large-scale empirical investigation in which judgments about health losses associated with many causes of disease and injury were elicited from the general public in diverse communities through a new, standardised approach.

Published
2012
Full Text
View/download PDF

12. Operative Techniques in the Fetal Rabbit

Author

Nelson, Jeffrey, Krummel, Thomas, Haynes, Jeffrey, Flood, Louise, Sauer, Loie, Flake, Alan, and Harrison, Michael

Abstract

The development of fetal surgical techniques has made the antenatal correction of congenital defects possible. These techniques have evolved from trials with animal models, permitting increasingly sophisticated operations with low morbidity and mortality. Experimental models range from large animals offering longer gestations but with single pregnancies and high cost, to smaller animals offering multiple pregnancies at reduced cost but with shorter gestations. This paper describes operative techniques in the fetal rabbit and its advantages as a fetal surgical model. Experience with the pregnant rabbit has shown it to be a suitable surgical model for several reasons. Pregnancies are multiple, increasing cost effectiveness and permitting operation on up to eight fetuses per litter without fetal loss. Techniques that promote fetal survival include local housing of does several days prior to operation and preoperative sedation. Spontaneous mask ventilation provides ease of anesthetic administration and titration. Overall surgery is well tolerated with a low incidence of intraoperative complications. Rabbit models have been used in the study of transamniotic fetal feeding, abdominal wall defects, and wound healing. These techniques have resulted in postoperative fetal viability approaching 90%, with negligible maternal mortality in over 4000 fetal operations, thereby making the rabbit a manageable cost-effective model of fetal surgery.

Published
1990
Full Text
View/download PDF

13. Fetal Skin Organ Culture

Author

Haynes, Jeffrey, Krummel, Thomas, Flood, Louise, Cohen, I. Kelman, and Diegelmann, Robert

Abstract

The fetal response to cutaneous injury has been investigated in a variety of models; most have studied the differences between fetal and adult healing mechanisms in vivo and in cell culture. Further disclosure of the cellular and biochemical events requires a model that can be manipulated to study single factors influencing fetal tissue repair without the complex interactions that occur in vivo, but in a system that more closely approximates normal skin than cell culture models. This paper presents a method for the organ culture of fetal skin and its advantages as a model to help elucidate fetal healing mechanisms. Skin sections (1 × 1 cm) excised from the backs of fetuses of New Zealand white rabbits on day 27 gestation (term = 31 days) were placed eccentrically in 65-mm culture dishes and fed daily with 2.5 mL of DMEM containing 10% fetal calf serum, antibiotics, and 10 mM ascorbic acid. A separate group, treated similarly, received 4-mm punch wounds to assess the in vitro response to wounding. Thespecimens were incubated at 37° Cin humidified room air on a rocker platform to provide alternate exposure of the skin to air and medium. Gross observation at 3 weeks showed cells extending into the central wound, indicating that viable cells were proliferating and/or migrating from the tissue. Skin was examined histologically and was viable over the 3-week period studied. Organ culture, by maintaining tissue in the natural extracellular matrix, allows cell-to-cell contact and communication to be maintained while allowing controlled environmental manipulation. In addition, the procedure is reproducible and assessment of tissue viability can be determined easily using histology. These advantages make fetal skin organ culture a valuable adjunct in the study of fetal skin and its response to wounding.

Published
1990
Full Text
View/download PDF

14. Analysis of Skin Grafting Techniques in the Fetal Rabbit

Author

Rice, Benjamin, Haynes, Jeffrey, Thomas, Brian, Flood, Louise, Cohen, I. Kelman, Diegelmann, Robert, and Krummel, Thomas

Abstract

The experimental model reported here was developed initially to examine the possibility of in utero coverage of congenital soft tissue defects using several types of reconstructive techniques. To pursue this, full-thickness skin grafts, pedicle flaps, and skin "islands" were fashioned on the backs of fetal rabbits; equivalent adult control wounds were also created. While all pedicle flaps and skin islands remained viable, none of the full-thickness grafts survived in the fetus. All adult control flaps, skin islands, and skin grafts were viable. Angiogenesis is crucial to full-thickness skin graft survival. These observations suggest that the death of full-thickness fetal skin grafts may be related to a failure of neovascularization in the graft bed. Further analysis using this model may help elucidate the factors involved in fetal angiogenesis. Additionally, this model may permit testing of putative angiogenic factors applied under a full-thickness skin graft; graft survival offers an easy, objective, and quantifiable means of data analysis.

Published
1991
Full Text
View/download PDF

15. Establishment of an adult rat fibroblast cell line for studies of collagenase regulation

Author

Lindblad, William and Flood, Louise

Abstract

Summary: Several dermal fibroblast lines have been established from explants taken from adult rats. The cells have been cultured for 2 yr and possess stable and well-defined growth characteristics through subculture 18. The cells are readily stored in liquid nitrogen with good viability after thawing. Collagenase activity secreted into the culture medium of the cells at different periods of growth has been examined. There is an 88% drop in total enzyme activity present in the medium between 4 and 14 d of culture, when the cells were plated to reach confluence at Day 8 to 10. A more pronounced fall is noted at earlier times when the cells are plated at a higher density. The correlation between DNA content of the cell monolayer and enzyme activity was −0.895, indicating a possible relationship between the growth of cells and collagenase release.

Published
1987
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results